Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Trials Evaluating Blood Tests to Guide Cancer Treatment

Blood sample tubes

Researchers in Australia are conducting clinical trials of blood tests among cancer patients to help determine the course of their treatment, including the need for chemotherapy. . . . → Read More: Trials Evaluating Blood Tests to Guide Cancer Treatment

Infectious Disease Sequencing Service, Training Launched

Aedes albopictus mosquito

A cloud-based open-source genomic sequencing program is underway to identify the source and nature of infectious diseases anywhere in the world. . . . → Read More: Infectious Disease Sequencing Service, Training Launched

Prenatal Genome Edits Prevent Inherited Liver Disorder

Editing DNA

Research with lab mice shows prenatal genome editing with techniques including Crispr can correct an inherited defect associated with a fatal congenital liver disorder. . . . → Read More: Prenatal Genome Edits Prevent Inherited Liver Disorder

Biotech in $3.7B Licensing Deal for Hepatitis-B

Hepatitis-B virus

A biotechnology company developing therapies that silence the actions of disease-causing genes is licensing its treatment program for hepatitis-B to Janssen Pharmaceuticals. . . . → Read More: Biotech in $3.7B Licensing Deal for Hepatitis-B

DNA Home Testing — Is It Worth It?

While so many of us are able to send away for one of those home testing kits to find out our ancestry, not to mention if we have a predilection towards certain diseases, are these kits valid at all? . . . → Read More: DNA Home Testing — Is It Worth It?

Mayo Clinic, Helix Partner on Genomic Analysis

DNA analysis graphic

Mayo Clinic and the company Helix Opco are providing a genomic analysis service for Mayo Clinic patients seeking more detailed insights into their genetic make-up and health outlook. . . . → Read More: Mayo Clinic, Helix Partner on Genomic Analysis

Genome Editing Offers Marketable Wild Tomato

Groundcherry plant

The groundcherry, a wild tomato plant that its devotees say has a delicious and unusual flavor, could be grown on farms for sale to consumers thanks to a genome editing project at two New York research institutes. . . . → Read More: Genome Editing Offers Marketable Wild Tomato

FDA Clears Genomic Bone Marrow Test for Low-Level Cancer

Detect cancer scrabble

(Marco Verch, Flickr)

1 Oct. 2018. The Food and Drug Administration on Friday authorized for marketing in the U.S. a system for high-speed analysis of bone marrow samples to find low levels of residual cancer cells. The agency’s announcement cleared the ClonoSeq assay developed by Adaptive Biotechnologies in Seattle to test for minimal residual . . . → Read More: FDA Clears Genomic Bone Marrow Test for Low-Level Cancer

Genome Centers Named for Precision Medicine Program

DNA methylation illustration

Three medical research centers in the U.S. will begin analyzing the DNA in specimen samples from participants in a large-scale precision medicine initiative conducted by National Institutes of Health. . . . → Read More: Genome Centers Named for Precision Medicine Program

Synthetic Antibody Neutralizing Gluten in Development

Oliver Spadiut

An academic-business team is developing a synthetic antibody to prevent gluten found in some grains from affecting the intestines of people with celiac disease, an intolerance of gluten. . . . → Read More: Synthetic Antibody Neutralizing Gluten in Development